271 related articles for article (PubMed ID: 35911474)
41. Saffron anti-metastatic properties, ancient spice novel application.
Arzi L; Hoshyar R
Crit Rev Food Sci Nutr; 2022; 62(14):3939-3950. PubMed ID: 33653190
[No Abstract] [Full Text] [Related]
42. Saffron: a natural product with potential pharmaceutical applications.
Christodoulou E; Kadoglou NP; Kostomitsopoulos N; Valsami G
J Pharm Pharmacol; 2015 Dec; 67(12):1634-49. PubMed ID: 26272123
[TBL] [Abstract][Full Text] [Related]
43. Transcriptome analysis reveals novel enzymes for apo-carotenoid biosynthesis in saffron and allows construction of a pathway for crocetin synthesis in yeast.
Tan H; Chen X; Liang N; Chen R; Chen J; Hu C; Li Q; Li Q; Pei W; Xiao W; Yuan Y; Chen W; Zhang L
J Exp Bot; 2019 Sep; 70(18):4819-4834. PubMed ID: 31056664
[TBL] [Abstract][Full Text] [Related]
44. A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease.
Finley JW; Gao S
J Agric Food Chem; 2017 Feb; 65(5):1005-1020. PubMed ID: 28098452
[TBL] [Abstract][Full Text] [Related]
45. Glucosylation of the saffron apocarotenoid crocetin by a glucosyltransferase isolated from Crocus sativus stigmas.
Moraga AR; Nohales PF; Pérez JA; Gómez-Gómez L
Planta; 2004 Oct; 219(6):955-66. PubMed ID: 15605174
[TBL] [Abstract][Full Text] [Related]
46. Saffron nephroprotective effects against medications and toxins: A review of preclinical data.
Zarei B; Elyasi S
Iran J Basic Med Sci; 2022 Apr; 25(4):419-434. PubMed ID: 35656071
[TBL] [Abstract][Full Text] [Related]
47. Patents on Therapeutic and Cosmetic Applications of Bioactives of Crocus Sativus L. and their Production through Synthetic Biology Methods: A Review.
Dawalbhakta M; Telang M
Recent Pat Biotechnol; 2017; 11(1):3-19. PubMed ID: 27842483
[TBL] [Abstract][Full Text] [Related]
48. Saffron (Crocus sativus) in the treatment of gastrointestinal cancers: Current findings and potential mechanisms of action.
Naeimi M; Shafiee M; Kermanshahi F; Khorasanchi Z; Khazaei M; Ryzhikov M; Avan A; Gorji N; Hassanian SM
J Cell Biochem; 2019 Oct; 120(10):16330-16339. PubMed ID: 31245875
[TBL] [Abstract][Full Text] [Related]
49. The potential role of saffron (Crocus Sativus L.) and its components in oxidative stress in diabetes mellitus: A systematic review.
Moini Jazani A; Karimi A; Nasimi Doost Azgomi R
Clin Nutr ESPEN; 2022 Apr; 48():148-157. PubMed ID: 35331485
[TBL] [Abstract][Full Text] [Related]
50. Saffron as an antidote or a protective agent against natural or chemical toxicities.
Razavi BM; Hosseinzadeh H
Daru; 2015 May; 23(1):31. PubMed ID: 25928729
[TBL] [Abstract][Full Text] [Related]
51. Crocus sativus L. (saffron) for cancer chemoprevention: A mini review.
Bhandari PR
J Tradit Complement Med; 2015 Apr; 5(2):81-7. PubMed ID: 26151016
[TBL] [Abstract][Full Text] [Related]
52. Proposed cytotoxic mechanisms of the saffron carotenoids crocin and crocetin on cancer cell lines.
Kim SH; Lee JM; Kim SC; Park CB; Lee PC
Biochem Cell Biol; 2014 Apr; 92(2):105-11. PubMed ID: 24697694
[TBL] [Abstract][Full Text] [Related]
53. Saffron (
El Midaoui A; Ghzaiel I; Vervandier-Fasseur D; Ksila M; Zarrouk A; Nury T; Khallouki F; El Hessni A; Ibrahimi SO; Latruffe N; Couture R; Kharoubi O; Brahmi F; Hammami S; Masmoudi-Kouki O; Hammami M; Ghrairi T; Vejux A; Lizard G
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276955
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive chemotaxonomic analysis of saffron crocus tepal and stamen samples, as raw materials with potential antidepressant activity.
Mottaghipisheh J; Mahmoodi Sourestani M; Kiss T; Horváth A; Tóth B; Ayanmanesh M; Khamushi A; Csupor D
J Pharm Biomed Anal; 2020 May; 184():113183. PubMed ID: 32105944
[TBL] [Abstract][Full Text] [Related]
55. Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients.
Samarghandian S; Borji A
Pharmacognosy Res; 2014 Apr; 6(2):99-107. PubMed ID: 24761112
[TBL] [Abstract][Full Text] [Related]
56. The Pharmacological Activities of
Butnariu M; Quispe C; Herrera-Bravo J; Sharifi-Rad J; Singh L; Aborehab NM; Bouyahya A; Venditti A; Sen S; Acharya K; Bashiry M; Ezzat SM; Setzer WN; Martorell M; Mileski KS; Bagiu IC; Docea AO; Calina D; Cho WC
Oxid Med Cell Longev; 2022; 2022():8214821. PubMed ID: 35198096
[No Abstract] [Full Text] [Related]
57. Impact of
Giannoulaki P; Kotzakioulafi E; Chourdakis M; Hatzitolios A; Didangelos T
Nutrients; 2020 May; 12(5):. PubMed ID: 32423173
[TBL] [Abstract][Full Text] [Related]
58. Bioaccessibility and Pharmacokinetics of a Commercial Saffron (
Almodóvar P; Briskey D; Rao A; Prodanov M; Inarejos-García AM
Evid Based Complement Alternat Med; 2020; 2020():1575730. PubMed ID: 32089715
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetic Properties of Saffron and its Active Components.
Hosseini A; Razavi BM; Hosseinzadeh H
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):383-390. PubMed ID: 29134501
[TBL] [Abstract][Full Text] [Related]
60. Saffron: a promising natural medicine in the treatment of metabolic syndrome.
Razavi BM; Hosseinzadeh H
J Sci Food Agric; 2017 Apr; 97(6):1679-1685. PubMed ID: 27861946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
